During the past decade, Dermatology Clinical Research Center of San Antonio conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 22 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 13 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Clinical Research Center of San Antonio" #1 sponsor was "LEO Pharma" with 4 trials, followed by "Peplin" with 4 trials sponsored, "Stiefel, a GSK Company" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Concert Pharmaceuticals" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Clinical Research Center of San Antonio" #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "ClinDatrix, Inc." with 1 trials as a collaborator and "Clinical Trials of Texas, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Clinical Research Center of San Antonio" are "Psoriasis" (9 trials), "Actinic Keratosis" (6 trials), "Plaque Psoriasis" (6 trials), "Acne Vulgaris" (4 trials) and "Actinic Keratoses" (3 trials). Many other conditions were trialed in "Dermatology Clinical Research Center of San Antonio" in a lesser frequency.

Most popular intervention types in "Dermatology Clinical Research Center of San Antonio" are "Drug" (48 trials), "Other" (7 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Vehicle" (3 trials), "Vehicle gel" (3 trials), "Abrocitinib 200 mg" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Clinical Research Center of San Antonio" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology Clinical Research Center of San Antonio". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in Dermatology Clinical Research Center of San Antonio, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Clinical Research Center of San Antonio, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".